Polar Asset Management Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-107,700	Closed	-$2.24M	–	758
2023 Q3	$2.24M	Buy	+107,700	New	+$2.24M	0.05%	353